Few environments test the limits of human physiology quite like high altitude. From the thin air of mountain plateaus to the oxygen-depleted summit zones of the world’s great peaks, the body’s response to reduced atmospheric pressure is a remarkable demonstration of adaptive biology. Understanding these mechanisms not only deepens our appreciation of human resilience but also has significant implications for medicine, sports science, and our broader knowledge of how organisms respond to environmental stress.
What Happens When You Go High
At sea level, the air we breathe contains approximately 21% oxygen — a concentration our bodies are finely tuned to exploit. As altitude increases, that percentage remains the same, but atmospheric pressure drops, meaning each breath delivers fewer oxygen molecules to the lungs. By the time you reach 5,500 metres above sea level, the effective oxygen available to the body is roughly half of what it is at sea level.
The immediate physiological response is straightforward: the body breathes faster. This hyperventilation helps compensate in the short term, but it also triggers a cascade of secondary effects. Blood carbon dioxide levels fall, causing a rise in blood pH — a condition known as respiratory alkalosis. The kidneys then begin excreting bicarbonate to restore acid-base balance, a process that takes several days and forms the foundation of what climbers call acclimatisation.
The Role of Haemoglobin and Erythropoietin
Over the medium term, the body deploys a more powerful adaptation: it produces more red blood cells. The hormone erythropoietin (EPO), secreted primarily by the kidneys in response to low oxygen tension, stimulates the bone marrow to increase red blood cell production. More red blood cells mean more haemoglobin, and more haemoglobin means a greater capacity to carry oxygen through the bloodstream to working muscles and vital organs.
This is why altitude training has become a fixture in elite endurance sports. Athletes who spend weeks at high elevation return to sea level with enhanced oxygen-carrying capacity — a perfectly legal physiological boost. The same mechanism, however, also thickens the blood, increasing the risk of clotting and stroke if hydration is neglected.
Altitude Sickness: When Adaptation Fails
Not everyone acclimatises successfully. Acute mountain sickness (AMS) affects a significant proportion of people who ascend too quickly, presenting with headache, nausea, fatigue, and disturbed sleep. In its most severe forms — high-altitude pulmonary oedema (HAPE) and high-altitude cerebral oedema (HACE) — altitude illness becomes life-threatening. The only reliable treatment for severe cases is immediate descent.
Individual susceptibility to altitude sickness is poorly predicted by age, gender, or fitness level, which makes it a particularly unpredictable hazard. Genetic factors, including variants in genes regulating the hypoxia-inducible factor (HIF) pathway, appear to play a significant role. Populations with long histories of high-altitude habitation, such as Tibetans and Andean communities, carry distinct genetic adaptations that allow them to function with remarkable efficiency at elevations that would incapacitate most lowlanders.
Kilimanjaro as a Scientific Case Study
Mount Kilimanjaro in Tanzania offers a uniquely accessible window into altitude physiology. Unlike the Himalayan giants, Kilimanjaro requires no technical climbing equipment, making it a common destination for trekkers of varying fitness levels — and, consequently, a frequent setting for altitude-related illness. Studies conducted on Kilimanjaro’s slopes have contributed meaningfully to our understanding of AMS onset and prevention.
The mountain is also attracting attention from the performance science community. John Rees-Evans, founder of Kilimanjaro guiding and expedition company Team Kilimanjaro, is in July 2026 attempting a speed record that begins not at a trailhead but at the mountain’s true geographic base at 777 metres above sea level — requiring a total vertical gain of 5,105 metres to Uhuru Peak. Such an attempt demands an extraordinary understanding of how the body manages oxygen debt across a continuous, rapid ascent, compressing into hours what most climbers spread across a week.
Practical Implications for Altitude Research
Beyond mountaineering, altitude physiology informs treatments for anaemia, chronic obstructive pulmonary disease, and even certain cancers. The HIF pathway, which coordinates the body’s response to low oxygen, is now a major target for pharmacological research. Scientists have developed drugs that mimic the effects of altitude training by activating HIF signalling — a discovery that earned the 2019 Nobel Prize in Physiology or Medicine.
Understanding how the body copes when oxygen is scarce also sheds light on foetal development, cardiac function, and wound healing — all processes that involve localised low-oxygen environments within the body itself.
Conclusion
The science of altitude is ultimately the science of adaptation — a story of how living systems sense their environment and respond with extraordinary flexibility. From genetic variants in ancient highland populations to the erythropoietic response triggered in a modern athlete’s kidneys, the body’s answer to thin air is a testament to the elegance of evolutionary biology. As researchers and record-breakers alike continue to push into the vertical frontier, our understanding of these mechanisms will only deepen.